Measurement
With Rx EDGE, pharmaceutical marketers have access to the metrics that are required to determine return on investment.
Solutions at the Shelf™ is one of the few direct-to-consumer marketing vehicles that can be reliably measured, enabling marketers to evaluate their results and optimize their investment.
Research methodology
Rx EDGE program impact is measured through an independent research company that analyzes weekly TRx and/or NRx script sales data using a matched-panel technique.
- Matched test and control panels, representative of the retailers’ store base, are created
- Matched pairs are developed based on key components such as sales patterns, geography, and demographics
- Panels are refined further based on volume during the base period, typically twelve weeks
- Usage of the base period insures that scripting volume was comparable in test and control stores prior to the Rx EDGE program launch
- Relative changes in sales are compared for the test vs. control panels to determine the Rx EDGE program’s effect on sales.
Rx EDGE delivers results
The chart below provides a snapshot of results across a variety of categories. See more details in our Solutions at the Shelf™ media kit, Spotlight on Results section.
Return on Investment…A key measurement of success
The sales lift data for each Rx EDGE cycle can be converted into manufacturer’s incremental revenue for a quick and accurate ROI analysis.
Rx EDGE has generated an average ROI of $6.00 for every dollar invested, a dramatically higher return than most other direct-to-consumer vehicles.
- Research conducted by Retail Intelligence Inc. for Rx EDGE retail pharmacy programs. Average TRx or NRx sales increase during post-installation period in supermarket, mass and/or drug outlets.
- ROI calculated using script lift and client supplied pricing data.